NCDN is a Potential Biomarker and Therapeutic Target for Glioblastoma
Xiaokai Huang,
Chengwu Xu,
Haipeng Dai
et al.
Abstract:Background:
Glioblastoma (GBM) is a type of central nervous system malignancy. In our study, we determined the effect of
NCDN
in GBM patients through The Cancer Genome Atlas (TCGA) data analysis, and studied the effects of
NCDN
on GBM cell function to estimate its potential as a therapeutic target.
Methods:
Gene expression profiles of glioblastoma cohort were acquired from TCGA database and analyzed to look for central genes that … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.